v3.26.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenues:
Expenses:    
Research and development 1,696,718 1,757,550
General and administrative 1,729,935 1,899,859
Total expenses 3,426,653 3,657,409
Loss from operations (3,426,653) (3,657,409)
Other income:    
Interest income 126,316 318,208
Net loss $ (3,300,337) $ (3,339,201)
Basic net loss per share $ (0.02) $ (0.02)
Diluted net loss per share $ (0.02) $ (0.02)
Weighted average common stock shares outstanding - basic 172,511,901 172,262,889
Weighted average common stock shares outstanding - diluted 172,511,901 172,262,889

Source